CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,667,436 | -28.3% | 56,600 | -20.6% | 0.00% | -42.9% |
| Q2 2023 | $2,324,697 | +45.3% | 71,266 | +104.1% | 0.01% | +40.0% |
| Q4 2022 | $1,599,759 | +128.2% | 34,914 | +141.4% | 0.01% | +66.7% |
| Q3 2022 | $701,000 | +59.3% | 14,464 | +29.1% | 0.00% | +200.0% |
| Q2 2022 | $440,000 | +69.2% | 11,200 | +96.5% | 0.00% | 0.0% |
| Q4 2021 | $260,000 | +29.4% | 5,700 | +1.8% | 0.00% | 0.0% |
| Q3 2021 | $201,000 | -22.4% | 5,600 | -53.3% | 0.00% | 0.0% |
| Q3 2020 | $259,000 | +32.8% | 11,979 | -29.9% | 0.00% | -50.0% |
| Q3 2019 | $195,000 | -21.4% | 17,100 | -22.3% | 0.00% | 0.0% |
| Q2 2019 | $248,000 | +202.4% | 22,000 | +117.8% | 0.00% | +100.0% |
| Q1 2019 | $82,000 | +720.0% | 10,100 | +1162.5% | 0.00% | – |
| Q4 2016 | $10,000 | -69.7% | 800 | -75.0% | 0.00% | – |
| Q4 2015 | $33,000 | +6.5% | 3,200 | -30.4% | 0.00% | – |
| Q3 2015 | $31,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |